» Articles » PMID: 35440671

Rapid Evolution of SARS-CoV-2 Challenges Human Defenses

Overview
Journal Sci Rep
Specialty Science
Date 2022 Apr 20
PMID 35440671
Authors
Affiliations
Soon will be listed here.
Abstract

The race between pathogens and their hosts is a major evolutionary driver, where both reshuffle their genomes to overcome and reorganize the defenses for infection, respectively. Evolutionary theory helps formulate predictions on the future evolutionary dynamics of SARS-CoV-2, which can be monitored through unprecedented real-time tracking of SARS-CoV-2 population genomics at the global scale. Here we quantify the accelerating evolution of SARS-CoV-2 by tracking the SARS-CoV-2 mutation globally, with a focus on the Receptor Binding Domain (RBD) of the spike protein determining infection success. We estimate that the > 820 million people that had been infected by October 5, 2021, produced up to 10 copies of the virus, with 12 new effective RBD variants appearing, on average, daily. Doubling of the number of RBD variants every 89 days, followed by selection of the most infective variants challenges our defenses and calls for a shift to anticipatory, rather than reactive tactics involving collaborative global sequencing and vaccination.

Citing Articles

Evolution takes multiple paths to evolvability when facing environmental change.

Kumawat B, Lalejini A, Acosta M, Zaman L Proc Natl Acad Sci U S A. 2024; 122(1):e2413930121.

PMID: 39739809 PMC: 11725885. DOI: 10.1073/pnas.2413930121.


Dynamic clade transitions and the influence of vaccination on the spatiotemporal circulation of SARS-CoV-2 variants.

Banho C, de Carvalho Marques B, Sacchetto L, Lima A, Parra M, Lima A NPJ Vaccines. 2024; 9(1):145.

PMID: 39127725 PMC: 11316783. DOI: 10.1038/s41541-024-00933-w.


Next-generation treatments: Immunotherapy and advanced therapies for COVID-19.

Arevalo-Romero J, Chingate-Lopez S, Camacho B, Almeciga-Diaz C, Ramirez-Segura C Heliyon. 2024; 10(5):e26423.

PMID: 38434363 PMC: 10907543. DOI: 10.1016/j.heliyon.2024.e26423.


Dynamic clade transitions and the influence of vaccine rollout on the spatiotemporal circulation of SARS-CoV-2 variants in São Paulo, Brazil.

Banho C, de Carvalho Marques B, Sacchetto L, Lima A, Parra M, Lima A Res Sq. 2024; .

PMID: 38343798 PMC: 10854302. DOI: 10.21203/rs.3.rs-3788142/v1.


Genomic and Epidemiologic Surveillance of SARS-CoV-2 in the Pandemic Period: Sequencing Network of the Lazio Region, Italy.

Rueca M, Berno G, Agresta A, Spaziante M, Gruber C, Fabeni L Viruses. 2023; 15(11).

PMID: 38005872 PMC: 10674723. DOI: 10.3390/v15112192.


References
1.
Alam I, Radovanovic A, Incitti R, Kamau A, Alarawi M, Azhar E . CovMT: an interactive SARS-CoV-2 mutation tracker, with a focus on critical variants. Lancet Infect Dis. 2021; 21(5):602. PMC: 7906688. DOI: 10.1016/S1473-3099(21)00078-5. View

2.
Singanayagam A, Hakki S, Dunning J, Madon K, Crone M, Koycheva A . Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. Lancet Infect Dis. 2021; 22(2):183-195. PMC: 8554486. DOI: 10.1016/S1473-3099(21)00648-4. View

3.
Levine-Tiefenbrun M, Yelin I, Alapi H, Katz R, Herzel E, Kuint J . Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2. Nat Med. 2021; 27(12):2108-2110. DOI: 10.1038/s41591-021-01575-4. View

4.
Morens D, Taubenberger J, Fauci A . Universal Coronavirus Vaccines - An Urgent Need. N Engl J Med. 2021; 386(4):297-299. PMC: 11000439. DOI: 10.1056/NEJMp2118468. View

5.
Wu S, Mertens A, Crider Y, Nguyen A, Pokpongkiat N, Djajadi S . Substantial underestimation of SARS-CoV-2 infection in the United States. Nat Commun. 2020; 11(1):4507. PMC: 7481226. DOI: 10.1038/s41467-020-18272-4. View